Atosiban vs. ritodrine as a tocolytic in external cephalic version at term: a prospective cohort study
Objective: To compare the success rate of external cephalic version (ECV) at term using ritodrine or atosiban as a tocolytic agent. Study design: Prospective cohort study with a sample of 236 pregnant women with a breech presentation at term, from November 2006 to March 2008. Data have been analyzed...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
|---|
| Format: |
E-Artikel |
|---|
| Erschienen: |
Walter de Gruyter ; 2010 |
|---|
| Schlagwörter: |
|---|
| Anmerkung: |
©2010 by Walter de Gruyter Berlin New York |
|---|---|
| Umfang: |
6 |
| Reproduktion: |
Walter de Gruyter Online Zeitschriften |
|---|---|
| Übergeordnetes Werk: |
Enthalten in: Journal of perinatal medicine - Berlin [u.a.] : de Gruyter, 1973, 38(2010), 1 vom: 05. Jan., Seite 23-28 |
| Übergeordnetes Werk: |
volume:38 ; year:2010 ; number:1 ; day:05 ; month:01 ; pages:23-28 ; extent:6 |
| Links: |
|---|
| DOI / URN: |
10.1515/jpm.2010.010 |
|---|
| Katalog-ID: |
NLEJ24714522X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLEJ24714522X | ||
| 003 | DE-627 | ||
| 005 | 20230506082219.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220814s2010 xx |||||o 00| ||und c | ||
| 024 | 7 | |a 10.1515/jpm.2010.010 |2 doi | |
| 028 | 5 | 2 | |a artikel_Grundlieferung.pp |
| 035 | |a (DE-627)NLEJ24714522X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 245 | 1 | 0 | |a Atosiban vs. ritodrine as a tocolytic in external cephalic version at term: a prospective cohort study |
| 264 | 1 | |b Walter de Gruyter |c 2010 | |
| 300 | |a 6 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a ©2010 by Walter de Gruyter Berlin New York | ||
| 520 | |a Objective: To compare the success rate of external cephalic version (ECV) at term using ritodrine or atosiban as a tocolytic agent. Study design: Prospective cohort study with a sample of 236 pregnant women with a breech presentation at term, from November 2006 to March 2008. Data have been analyzed from the moment the cephalic version is performed until the time of delivery. Results: ECV success rate using ritodrine as a tocolytic agent was 56.8% compared to 31.4% with atosiban. Ritodrine increases the version success potential more significantly than atosiban (P<0.05). In both cases, the use of ECV reduced the rate of cesarean sections, although a higher number of versions are required with atosiban [numbers needed to treat (NNT)=9.08] to avoid a cesarean section compared to ritodrine (NNT=3.41). Conclusions: Ritodrine seems better than atosiban as tocolytic agent for ECVs. | ||
| 533 | |f Walter de Gruyter Online Zeitschriften | ||
| 650 | 4 | |a Breech presentation | |
| 650 | 4 | |a external cephalic version (ECV) | |
| 650 | 4 | |a ritodrine | |
| 650 | 4 | |a tocolityc agents | |
| 650 | 4 | |a vasotocin | |
| 700 | 1 | |a Burgos, Jorge |4 oth | |
| 700 | 1 | |a Eguiguren, Nekane |4 oth | |
| 700 | 1 | |a Quintana, Eider |4 oth | |
| 700 | 1 | |a Cobos, Patricia |4 oth | |
| 700 | 1 | |a del Mar Centeno, Maria |4 oth | |
| 700 | 1 | |a Larrieta, Rosa |4 oth | |
| 700 | 1 | |a Fernández-Llebrez, Luis |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of perinatal medicine |d Berlin [u.a.] : de Gruyter, 1973 |g 38(2010), 1 vom: 05. Jan., Seite 23-28 |w (DE-627)NLEJ248236229 |w (DE-600)1467968-1 |x 16193997 |7 nnns |
| 773 | 1 | 8 | |g volume:38 |g year:2010 |g number:1 |g day:05 |g month:01 |g pages:23-28 |g extent:6 |
| 856 | 4 | 0 | |u https://doi.org/10.1515/jpm.2010.010 |z Deutschlandweit zugänglich |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a ZDB-1-DGR | ||
| 912 | |a GBV_NL_ARTICLE | ||
| 951 | |a AR | ||
| 952 | |d 38 |j 2010 |e 1 |b 05 |c 01 |h 23-28 |g 6 | ||
| matchkey_str |
article:16193997:2010----::tsbnsiornaaooyiietracpaivrintem |
|---|---|
| hierarchy_sort_str |
2010 |
| publishDate |
2010 |
| allfields |
10.1515/jpm.2010.010 doi artikel_Grundlieferung.pp (DE-627)NLEJ24714522X DE-627 ger DE-627 rakwb Atosiban vs. ritodrine as a tocolytic in external cephalic version at term: a prospective cohort study Walter de Gruyter 2010 6 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier ©2010 by Walter de Gruyter Berlin New York Objective: To compare the success rate of external cephalic version (ECV) at term using ritodrine or atosiban as a tocolytic agent. Study design: Prospective cohort study with a sample of 236 pregnant women with a breech presentation at term, from November 2006 to March 2008. Data have been analyzed from the moment the cephalic version is performed until the time of delivery. Results: ECV success rate using ritodrine as a tocolytic agent was 56.8% compared to 31.4% with atosiban. Ritodrine increases the version success potential more significantly than atosiban (P<0.05). In both cases, the use of ECV reduced the rate of cesarean sections, although a higher number of versions are required with atosiban [numbers needed to treat (NNT)=9.08] to avoid a cesarean section compared to ritodrine (NNT=3.41). Conclusions: Ritodrine seems better than atosiban as tocolytic agent for ECVs. Walter de Gruyter Online Zeitschriften Breech presentation external cephalic version (ECV) ritodrine tocolityc agents vasotocin Burgos, Jorge oth Eguiguren, Nekane oth Quintana, Eider oth Cobos, Patricia oth del Mar Centeno, Maria oth Larrieta, Rosa oth Fernández-Llebrez, Luis oth Enthalten in Journal of perinatal medicine Berlin [u.a.] : de Gruyter, 1973 38(2010), 1 vom: 05. Jan., Seite 23-28 (DE-627)NLEJ248236229 (DE-600)1467968-1 16193997 nnns volume:38 year:2010 number:1 day:05 month:01 pages:23-28 extent:6 https://doi.org/10.1515/jpm.2010.010 Deutschlandweit zugänglich GBV_USEFLAG_U ZDB-1-DGR GBV_NL_ARTICLE AR 38 2010 1 05 01 23-28 6 |
| spelling |
10.1515/jpm.2010.010 doi artikel_Grundlieferung.pp (DE-627)NLEJ24714522X DE-627 ger DE-627 rakwb Atosiban vs. ritodrine as a tocolytic in external cephalic version at term: a prospective cohort study Walter de Gruyter 2010 6 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier ©2010 by Walter de Gruyter Berlin New York Objective: To compare the success rate of external cephalic version (ECV) at term using ritodrine or atosiban as a tocolytic agent. Study design: Prospective cohort study with a sample of 236 pregnant women with a breech presentation at term, from November 2006 to March 2008. Data have been analyzed from the moment the cephalic version is performed until the time of delivery. Results: ECV success rate using ritodrine as a tocolytic agent was 56.8% compared to 31.4% with atosiban. Ritodrine increases the version success potential more significantly than atosiban (P<0.05). In both cases, the use of ECV reduced the rate of cesarean sections, although a higher number of versions are required with atosiban [numbers needed to treat (NNT)=9.08] to avoid a cesarean section compared to ritodrine (NNT=3.41). Conclusions: Ritodrine seems better than atosiban as tocolytic agent for ECVs. Walter de Gruyter Online Zeitschriften Breech presentation external cephalic version (ECV) ritodrine tocolityc agents vasotocin Burgos, Jorge oth Eguiguren, Nekane oth Quintana, Eider oth Cobos, Patricia oth del Mar Centeno, Maria oth Larrieta, Rosa oth Fernández-Llebrez, Luis oth Enthalten in Journal of perinatal medicine Berlin [u.a.] : de Gruyter, 1973 38(2010), 1 vom: 05. Jan., Seite 23-28 (DE-627)NLEJ248236229 (DE-600)1467968-1 16193997 nnns volume:38 year:2010 number:1 day:05 month:01 pages:23-28 extent:6 https://doi.org/10.1515/jpm.2010.010 Deutschlandweit zugänglich GBV_USEFLAG_U ZDB-1-DGR GBV_NL_ARTICLE AR 38 2010 1 05 01 23-28 6 |
| allfields_unstemmed |
10.1515/jpm.2010.010 doi artikel_Grundlieferung.pp (DE-627)NLEJ24714522X DE-627 ger DE-627 rakwb Atosiban vs. ritodrine as a tocolytic in external cephalic version at term: a prospective cohort study Walter de Gruyter 2010 6 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier ©2010 by Walter de Gruyter Berlin New York Objective: To compare the success rate of external cephalic version (ECV) at term using ritodrine or atosiban as a tocolytic agent. Study design: Prospective cohort study with a sample of 236 pregnant women with a breech presentation at term, from November 2006 to March 2008. Data have been analyzed from the moment the cephalic version is performed until the time of delivery. Results: ECV success rate using ritodrine as a tocolytic agent was 56.8% compared to 31.4% with atosiban. Ritodrine increases the version success potential more significantly than atosiban (P<0.05). In both cases, the use of ECV reduced the rate of cesarean sections, although a higher number of versions are required with atosiban [numbers needed to treat (NNT)=9.08] to avoid a cesarean section compared to ritodrine (NNT=3.41). Conclusions: Ritodrine seems better than atosiban as tocolytic agent for ECVs. Walter de Gruyter Online Zeitschriften Breech presentation external cephalic version (ECV) ritodrine tocolityc agents vasotocin Burgos, Jorge oth Eguiguren, Nekane oth Quintana, Eider oth Cobos, Patricia oth del Mar Centeno, Maria oth Larrieta, Rosa oth Fernández-Llebrez, Luis oth Enthalten in Journal of perinatal medicine Berlin [u.a.] : de Gruyter, 1973 38(2010), 1 vom: 05. Jan., Seite 23-28 (DE-627)NLEJ248236229 (DE-600)1467968-1 16193997 nnns volume:38 year:2010 number:1 day:05 month:01 pages:23-28 extent:6 https://doi.org/10.1515/jpm.2010.010 Deutschlandweit zugänglich GBV_USEFLAG_U ZDB-1-DGR GBV_NL_ARTICLE AR 38 2010 1 05 01 23-28 6 |
| allfieldsGer |
10.1515/jpm.2010.010 doi artikel_Grundlieferung.pp (DE-627)NLEJ24714522X DE-627 ger DE-627 rakwb Atosiban vs. ritodrine as a tocolytic in external cephalic version at term: a prospective cohort study Walter de Gruyter 2010 6 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier ©2010 by Walter de Gruyter Berlin New York Objective: To compare the success rate of external cephalic version (ECV) at term using ritodrine or atosiban as a tocolytic agent. Study design: Prospective cohort study with a sample of 236 pregnant women with a breech presentation at term, from November 2006 to March 2008. Data have been analyzed from the moment the cephalic version is performed until the time of delivery. Results: ECV success rate using ritodrine as a tocolytic agent was 56.8% compared to 31.4% with atosiban. Ritodrine increases the version success potential more significantly than atosiban (P<0.05). In both cases, the use of ECV reduced the rate of cesarean sections, although a higher number of versions are required with atosiban [numbers needed to treat (NNT)=9.08] to avoid a cesarean section compared to ritodrine (NNT=3.41). Conclusions: Ritodrine seems better than atosiban as tocolytic agent for ECVs. Walter de Gruyter Online Zeitschriften Breech presentation external cephalic version (ECV) ritodrine tocolityc agents vasotocin Burgos, Jorge oth Eguiguren, Nekane oth Quintana, Eider oth Cobos, Patricia oth del Mar Centeno, Maria oth Larrieta, Rosa oth Fernández-Llebrez, Luis oth Enthalten in Journal of perinatal medicine Berlin [u.a.] : de Gruyter, 1973 38(2010), 1 vom: 05. Jan., Seite 23-28 (DE-627)NLEJ248236229 (DE-600)1467968-1 16193997 nnns volume:38 year:2010 number:1 day:05 month:01 pages:23-28 extent:6 https://doi.org/10.1515/jpm.2010.010 Deutschlandweit zugänglich GBV_USEFLAG_U ZDB-1-DGR GBV_NL_ARTICLE AR 38 2010 1 05 01 23-28 6 |
| allfieldsSound |
10.1515/jpm.2010.010 doi artikel_Grundlieferung.pp (DE-627)NLEJ24714522X DE-627 ger DE-627 rakwb Atosiban vs. ritodrine as a tocolytic in external cephalic version at term: a prospective cohort study Walter de Gruyter 2010 6 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier ©2010 by Walter de Gruyter Berlin New York Objective: To compare the success rate of external cephalic version (ECV) at term using ritodrine or atosiban as a tocolytic agent. Study design: Prospective cohort study with a sample of 236 pregnant women with a breech presentation at term, from November 2006 to March 2008. Data have been analyzed from the moment the cephalic version is performed until the time of delivery. Results: ECV success rate using ritodrine as a tocolytic agent was 56.8% compared to 31.4% with atosiban. Ritodrine increases the version success potential more significantly than atosiban (P<0.05). In both cases, the use of ECV reduced the rate of cesarean sections, although a higher number of versions are required with atosiban [numbers needed to treat (NNT)=9.08] to avoid a cesarean section compared to ritodrine (NNT=3.41). Conclusions: Ritodrine seems better than atosiban as tocolytic agent for ECVs. Walter de Gruyter Online Zeitschriften Breech presentation external cephalic version (ECV) ritodrine tocolityc agents vasotocin Burgos, Jorge oth Eguiguren, Nekane oth Quintana, Eider oth Cobos, Patricia oth del Mar Centeno, Maria oth Larrieta, Rosa oth Fernández-Llebrez, Luis oth Enthalten in Journal of perinatal medicine Berlin [u.a.] : de Gruyter, 1973 38(2010), 1 vom: 05. Jan., Seite 23-28 (DE-627)NLEJ248236229 (DE-600)1467968-1 16193997 nnns volume:38 year:2010 number:1 day:05 month:01 pages:23-28 extent:6 https://doi.org/10.1515/jpm.2010.010 Deutschlandweit zugänglich GBV_USEFLAG_U ZDB-1-DGR GBV_NL_ARTICLE AR 38 2010 1 05 01 23-28 6 |
| source |
Enthalten in Journal of perinatal medicine 38(2010), 1 vom: 05. Jan., Seite 23-28 volume:38 year:2010 number:1 day:05 month:01 pages:23-28 extent:6 |
| sourceStr |
Enthalten in Journal of perinatal medicine 38(2010), 1 vom: 05. Jan., Seite 23-28 volume:38 year:2010 number:1 day:05 month:01 pages:23-28 extent:6 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
Breech presentation external cephalic version (ECV) ritodrine tocolityc agents vasotocin |
| isfreeaccess_bool |
false |
| container_title |
Journal of perinatal medicine |
| authorswithroles_txt_mv |
Burgos, Jorge @@oth@@ Eguiguren, Nekane @@oth@@ Quintana, Eider @@oth@@ Cobos, Patricia @@oth@@ del Mar Centeno, Maria @@oth@@ Larrieta, Rosa @@oth@@ Fernández-Llebrez, Luis @@oth@@ |
| publishDateDaySort_date |
2010-01-05T00:00:00Z |
| hierarchy_top_id |
NLEJ248236229 |
| id |
NLEJ24714522X |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">NLEJ24714522X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230506082219.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">220814s2010 xx |||||o 00| ||und c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1515/jpm.2010.010</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">artikel_Grundlieferung.pp</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)NLEJ24714522X</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Atosiban vs. ritodrine as a tocolytic in external cephalic version at term: a prospective cohort study</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="b">Walter de Gruyter</subfield><subfield code="c">2010</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">6</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">©2010 by Walter de Gruyter Berlin New York</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Objective: To compare the success rate of external cephalic version (ECV) at term using ritodrine or atosiban as a tocolytic agent. Study design: Prospective cohort study with a sample of 236 pregnant women with a breech presentation at term, from November 2006 to March 2008. Data have been analyzed from the moment the cephalic version is performed until the time of delivery. Results: ECV success rate using ritodrine as a tocolytic agent was 56.8% compared to 31.4% with atosiban. Ritodrine increases the version success potential more significantly than atosiban (P<0.05). In both cases, the use of ECV reduced the rate of cesarean sections, although a higher number of versions are required with atosiban [numbers needed to treat (NNT)=9.08] to avoid a cesarean section compared to ritodrine (NNT=3.41). Conclusions: Ritodrine seems better than atosiban as tocolytic agent for ECVs.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="f">Walter de Gruyter Online Zeitschriften</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Breech presentation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">external cephalic version (ECV)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">ritodrine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">tocolityc agents</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">vasotocin</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Burgos, Jorge</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Eguiguren, Nekane</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Quintana, Eider</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cobos, Patricia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">del Mar Centeno, Maria</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Larrieta, Rosa</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fernández-Llebrez, Luis</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Journal of perinatal medicine</subfield><subfield code="d">Berlin [u.a.] : de Gruyter, 1973</subfield><subfield code="g">38(2010), 1 vom: 05. Jan., Seite 23-28</subfield><subfield code="w">(DE-627)NLEJ248236229</subfield><subfield code="w">(DE-600)1467968-1</subfield><subfield code="x">16193997</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:38</subfield><subfield code="g">year:2010</subfield><subfield code="g">number:1</subfield><subfield code="g">day:05</subfield><subfield code="g">month:01</subfield><subfield code="g">pages:23-28</subfield><subfield code="g">extent:6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1515/jpm.2010.010</subfield><subfield code="z">Deutschlandweit zugänglich</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-DGR</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_NL_ARTICLE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">38</subfield><subfield code="j">2010</subfield><subfield code="e">1</subfield><subfield code="b">05</subfield><subfield code="c">01</subfield><subfield code="h">23-28</subfield><subfield code="g">6</subfield></datafield></record></collection>
|
| series2 |
Walter de Gruyter Online Zeitschriften |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)NLEJ248236229 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| collection |
NL |
| remote_str |
true |
| illustrated |
Not Illustrated |
| issn |
16193997 |
| topic_title |
Atosiban vs. ritodrine as a tocolytic in external cephalic version at term: a prospective cohort study Breech presentation external cephalic version (ECV) ritodrine tocolityc agents vasotocin |
| publisher |
Walter de Gruyter |
| publisherStr |
Walter de Gruyter |
| topic |
misc Breech presentation misc external cephalic version (ECV) misc ritodrine misc tocolityc agents misc vasotocin |
| spellingShingle |
misc Breech presentation misc external cephalic version (ECV) misc ritodrine misc tocolityc agents misc vasotocin Atosiban vs. ritodrine as a tocolytic in external cephalic version at term: a prospective cohort study |
| topic_unstemmed |
misc Breech presentation misc external cephalic version (ECV) misc ritodrine misc tocolityc agents misc vasotocin |
| topic_browse |
misc Breech presentation misc external cephalic version (ECV) misc ritodrine misc tocolityc agents misc vasotocin |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
cr |
| author2_variant |
j b jb n e ne e q eq p c pc m c m d mcm mcmd r l rl l f l lfl |
| hierarchy_parent_title |
Journal of perinatal medicine |
| hierarchy_parent_id |
NLEJ248236229 |
| hierarchy_top_title |
Journal of perinatal medicine |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)NLEJ248236229 (DE-600)1467968-1 |
| title |
Atosiban vs. ritodrine as a tocolytic in external cephalic version at term: a prospective cohort study |
| ctrlnum |
(DE-627)NLEJ24714522X |
| title_full |
Atosiban vs. ritodrine as a tocolytic in external cephalic version at term: a prospective cohort study |
| journal |
Journal of perinatal medicine |
| journalStr |
Journal of perinatal medicine |
| isOA_bool |
false |
| recordtype |
marc |
| publishDateSort |
2010 |
| contenttype_str_mv |
txt |
| container_start_page |
23 |
| container_volume |
38 |
| physical |
6 |
| format_se |
Elektronische Aufsätze |
| doi_str_mv |
10.1515/jpm.2010.010 |
| title_sort |
atosiban vs. ritodrine as a tocolytic in external cephalic version at term: a prospective cohort study |
| title_auth |
Atosiban vs. ritodrine as a tocolytic in external cephalic version at term: a prospective cohort study |
| abstract |
Objective: To compare the success rate of external cephalic version (ECV) at term using ritodrine or atosiban as a tocolytic agent. Study design: Prospective cohort study with a sample of 236 pregnant women with a breech presentation at term, from November 2006 to March 2008. Data have been analyzed from the moment the cephalic version is performed until the time of delivery. Results: ECV success rate using ritodrine as a tocolytic agent was 56.8% compared to 31.4% with atosiban. Ritodrine increases the version success potential more significantly than atosiban (P<0.05). In both cases, the use of ECV reduced the rate of cesarean sections, although a higher number of versions are required with atosiban [numbers needed to treat (NNT)=9.08] to avoid a cesarean section compared to ritodrine (NNT=3.41). Conclusions: Ritodrine seems better than atosiban as tocolytic agent for ECVs. ©2010 by Walter de Gruyter Berlin New York |
| abstractGer |
Objective: To compare the success rate of external cephalic version (ECV) at term using ritodrine or atosiban as a tocolytic agent. Study design: Prospective cohort study with a sample of 236 pregnant women with a breech presentation at term, from November 2006 to March 2008. Data have been analyzed from the moment the cephalic version is performed until the time of delivery. Results: ECV success rate using ritodrine as a tocolytic agent was 56.8% compared to 31.4% with atosiban. Ritodrine increases the version success potential more significantly than atosiban (P<0.05). In both cases, the use of ECV reduced the rate of cesarean sections, although a higher number of versions are required with atosiban [numbers needed to treat (NNT)=9.08] to avoid a cesarean section compared to ritodrine (NNT=3.41). Conclusions: Ritodrine seems better than atosiban as tocolytic agent for ECVs. ©2010 by Walter de Gruyter Berlin New York |
| abstract_unstemmed |
Objective: To compare the success rate of external cephalic version (ECV) at term using ritodrine or atosiban as a tocolytic agent. Study design: Prospective cohort study with a sample of 236 pregnant women with a breech presentation at term, from November 2006 to March 2008. Data have been analyzed from the moment the cephalic version is performed until the time of delivery. Results: ECV success rate using ritodrine as a tocolytic agent was 56.8% compared to 31.4% with atosiban. Ritodrine increases the version success potential more significantly than atosiban (P<0.05). In both cases, the use of ECV reduced the rate of cesarean sections, although a higher number of versions are required with atosiban [numbers needed to treat (NNT)=9.08] to avoid a cesarean section compared to ritodrine (NNT=3.41). Conclusions: Ritodrine seems better than atosiban as tocolytic agent for ECVs. ©2010 by Walter de Gruyter Berlin New York |
| collection_details |
GBV_USEFLAG_U ZDB-1-DGR GBV_NL_ARTICLE |
| container_issue |
1 |
| title_short |
Atosiban vs. ritodrine as a tocolytic in external cephalic version at term: a prospective cohort study |
| url |
https://doi.org/10.1515/jpm.2010.010 |
| remote_bool |
true |
| author2 |
Burgos, Jorge Eguiguren, Nekane Quintana, Eider Cobos, Patricia del Mar Centeno, Maria Larrieta, Rosa Fernández-Llebrez, Luis |
| author2Str |
Burgos, Jorge Eguiguren, Nekane Quintana, Eider Cobos, Patricia del Mar Centeno, Maria Larrieta, Rosa Fernández-Llebrez, Luis |
| ppnlink |
NLEJ248236229 |
| mediatype_str_mv |
c |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth |
| doi_str |
10.1515/jpm.2010.010 |
| up_date |
2024-07-06T10:04:32.381Z |
| _version_ |
1803823635372179456 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">NLEJ24714522X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230506082219.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">220814s2010 xx |||||o 00| ||und c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1515/jpm.2010.010</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">artikel_Grundlieferung.pp</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)NLEJ24714522X</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Atosiban vs. ritodrine as a tocolytic in external cephalic version at term: a prospective cohort study</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="b">Walter de Gruyter</subfield><subfield code="c">2010</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">6</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">©2010 by Walter de Gruyter Berlin New York</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Objective: To compare the success rate of external cephalic version (ECV) at term using ritodrine or atosiban as a tocolytic agent. Study design: Prospective cohort study with a sample of 236 pregnant women with a breech presentation at term, from November 2006 to March 2008. Data have been analyzed from the moment the cephalic version is performed until the time of delivery. Results: ECV success rate using ritodrine as a tocolytic agent was 56.8% compared to 31.4% with atosiban. Ritodrine increases the version success potential more significantly than atosiban (P<0.05). In both cases, the use of ECV reduced the rate of cesarean sections, although a higher number of versions are required with atosiban [numbers needed to treat (NNT)=9.08] to avoid a cesarean section compared to ritodrine (NNT=3.41). Conclusions: Ritodrine seems better than atosiban as tocolytic agent for ECVs.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="f">Walter de Gruyter Online Zeitschriften</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Breech presentation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">external cephalic version (ECV)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">ritodrine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">tocolityc agents</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">vasotocin</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Burgos, Jorge</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Eguiguren, Nekane</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Quintana, Eider</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cobos, Patricia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">del Mar Centeno, Maria</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Larrieta, Rosa</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fernández-Llebrez, Luis</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Journal of perinatal medicine</subfield><subfield code="d">Berlin [u.a.] : de Gruyter, 1973</subfield><subfield code="g">38(2010), 1 vom: 05. Jan., Seite 23-28</subfield><subfield code="w">(DE-627)NLEJ248236229</subfield><subfield code="w">(DE-600)1467968-1</subfield><subfield code="x">16193997</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:38</subfield><subfield code="g">year:2010</subfield><subfield code="g">number:1</subfield><subfield code="g">day:05</subfield><subfield code="g">month:01</subfield><subfield code="g">pages:23-28</subfield><subfield code="g">extent:6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1515/jpm.2010.010</subfield><subfield code="z">Deutschlandweit zugänglich</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-DGR</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_NL_ARTICLE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">38</subfield><subfield code="j">2010</subfield><subfield code="e">1</subfield><subfield code="b">05</subfield><subfield code="c">01</subfield><subfield code="h">23-28</subfield><subfield code="g">6</subfield></datafield></record></collection>
|
| score |
7.4028025 |